Strata Oncology Names Scott A. Tomlins, M.D., Ph.D., Chief Medical Officer

Thursday, November 8, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

ANN ARBOR, Mich., Nov. 8, 2018 /PRNewswire/ -- Strata Oncology, a leading precision oncology company, today announced

the appointment of Scott A. Tomlins, M.D., Ph.D., as the Company's Chief Medical Officer. Dr. Tomlins is a leading molecular pathologist and cancer genomics researcher.

"We are thrilled to have Scott, one of Strata's

co-founders, join our team full-time," said Dan Rhodes, Ph.D., Chief Executive Officer of Strata Oncology. "As we continue to scale and deliver on the promise of our precision oncology platform, Scott's unrivaled expertise in precision cancer diagnostics and translational research will be critical to achieving our objectives." 

Dr. Tomlins brings to Strata Oncology extensive experience in cancer genomics, laboratory test development and delivery, and translational research. Prior to joining the company, Dr. Tomlins was an Associate Professor of Pathology at the University of Michigan, where his research focused on using high-throughput techniques to characterize the cancer genome and transcriptome to understand cancer biology and identify clinically relevant biomarkers and therapeutic targets. Among his many contributions to the field is the discovery and characterization of TMPRSS2:ETS gene fusions in prostate cancer. As a practicing pathologist, he led the translation of ETS gene fusions into diagnostic and early detection biomarkers. Dr. Tomlins' laboratory also developed, validated and applied multiple next generation sequencing approaches applicable to a variety of biospecimens.

Dr. Tomlins has received numerous academic honors and awards, holds multiple issued patents, and has co-authored over 200 manuscripts and textbook chapters. He received his M.D. and Ph.D. at the University of Michigan Medical School and completed a residency in Anatomic Pathology at the University of Michigan Health System. Dr. Tomlins is maintaining an adjunct faculty position at the University of Michigan Medical School.

About Strata OncologyStrata Oncology is a precision medicine company dedicated to transforming cancer care by systematizing precision oncology across a network of health systems and pharma companies. We empower health systems to deliver a cost-effective, system-wide precision oncology program, one that integrates cutting-edge molecular profiling and precision therapy trials with routine care, so that all advanced cancer patients have the opportunity to benefit. This large network of trial-ready health systems provides a mechanism to rapidly and predictably enroll precision therapy trials. For more information visit www.strataoncology.com.

ContactsStrata OncologyStrata Oncology Media Relations734-527-1000media@strataoncology.com

Cision View original content:http://www.prnewswire.com/news-releases/strata-oncology-names-scott-a-tomlins-md-phd-chief-medical-officer-300746510.html

SOURCE STRATA ONCOLOGY



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store